Pronutria Biosciences Named by Forbes as the Hottest Healthcare Startup in 2015

CAMBRIDGE, Mass.--()--Pronutria Biosciences™ Inc., a biotechnology company pioneering a new class of therapeutics, announced today that it was named as the leading Healthcare Startup in the industry-wide Forbes 2015 Hottest Startup list.

“We believe our strategy will lead to life transforming impact for patients and their families.”

Pronutria is at the forefront of developing amino acid-based products for patients facing serious medical conditions who currently have few or no options. Leveraging its unique knowledge of amino acid biology, Pronutria is rapidly advancing clinical stage candidates in areas including muscle, metabolic, neurological and liver disorders.

“We are delighted that Forbes has recognized the value we are creating with our groundbreaking approach,” said Robert Connelly, President and Chief Executive Officer at Pronutria. “We believe our strategy will lead to life transforming impact for patients and their families.”

About Forbes’ Hottest Startups of 2015

Forbes’ annual Hottest Startups list highlights the most in-demand startups of the year, ranking companies by the fastest growing valuations between funding rounds. The 2015 Forbes Hottest Startups list uses data from Pitchbook, a private company research firm. Only private companies that raised new funding rounds in 2015, analyzed via regulatory filings, were included. Combined, the top 50 hottest startups raised over $7 billion this year and have a total valuation close to $120 billion.

About Pronutria Biosciences

Pronutria Biosciences is pioneering new nutritional and therapeutic modalities: amino acid biologics. Amino acids (AA) are known as the “building blocks of life,” and are fundamental regulators of health. The entire body, ranging from microscopic cells to organs, is dependent on tightly controlled AA homeostasis. More than 2000 disorders are linked to differences in AA metabolism and transport. The dysregulation of AAs cause and/or drive the onset of a number of conditions. Using insights from a clinically validated body of evidence, Pronutria Biosciences is developing first-in-class therapeutic and nutritional solutions to these conditions with a focus on amino acid biology. This novel approach allows us to precisely target biology that was previously inaccessible, providing a unique opportunity to address a variety of serious nutritional and medical conditions, such as muscle, metabolic, neurological, and hepatic disorders. Founded by Flagship VentureLabs, privately-held Pronutria Biosciences is based in Cambridge MA. For more information, please visit www.pronutriabio.com.

Contacts

For Pronutria Biosciences:
MEDIA:
Feinstein Kean Healthcare
Liz Melone, 617-761-6727
liz.melone@fkhealth.com
or
THE COMPANY:
Christine Lafontant, 617-868-0949
clafontant@pronutriabio.com

Release Summary

Pronutria Biosciences announced that it was named as the leading Healthcare Startup in the industry-wide Forbes 2015 Hottest Startup list.

Pronutria Biosciences